There are 717 resources available
259O - Treatment patterns and outcomes in older patients with mantle cell lymphoma in an Asian population
Presenter: Xinyi Yang
Session: Proffered paper session on Haematological malignancies
Resources:
Abstract
Slides
Webcast
1O - KEYNOTE-522 Asian subgroup: Phase III study of neoadjuvant pembrolizumab (pembro) vs placebo (pbo) + chemotherapy (chemo) followed by adjuvant pembro vs pbo for early triple-negative breast cancer (TNBC)
Presenter: Rebecca Dent
Session: Proffered paper session on Breast cancer
Resources:
Abstract
Slides
Webcast
43O - Phase III KEYNOTE-355 study of pembrolizumab (pembro) vs placebo (pbo) + chemotherapy (chemo) for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC): Results for patients (Pts) enrolled in Asia
Presenter: Mastura Md Yusof
Session: Proffered paper session on Breast cancer
Resources:
Abstract
Slides
Webcast
44O - Pembrolizumab (pembro) vs chemotherapy (chemo) for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-119 Asia-Pacific subpopulation
Presenter: Seock-Ah Im
Session: Proffered paper session on Breast cancer
Resources:
Abstract
Slides
Webcast
45O - Abemaciclib plus fulvestrant in East Asian women with HR+, HER2- advanced breast cancer: Overall survival from MONARCH 2
Presenter: Chiun-Sheng Huang
Session: Proffered paper session on Breast cancer
Resources:
Abstract
Slides
Webcast
46O - Neratinib + capecitabine (N+C) vs lapatinib + capecitabine (L+C) in Asians with HER2+ metastatic breast cancer (MBC) previously treated with two or more HER2-directed regimens: A Pan-Asian analysis of the phase III NALA trial
Presenter: Ming Shen Dai
Session: Proffered paper session on Breast cancer
Resources:
Abstract
Slides
Webcast
LBA2 - Sintilimab plus bevacizumab biosimilar vs sorafenib as first-line treatment for advanced hepatocellular carcinoma (ORIENT-32)2
Presenter: Zhenggang Ren
Session: Proffered paper session on Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
LBA4 - GEMSTONE-302: A phase III study of platinum-based chemotherapy (chemo) with placebo or CS1001, an anti-PDL1 antibody, for first-line (1L) advanced non-small cell lung cancer (NSCLC)
Presenter: Caicun Zhou
Session: Proffered paper session on Thoracic cancers
Resources:
Abstract
Slides
Webcast
Invited Discussant abstracts LBA4 and 375O
Presenter: Martin Reck
Session: Proffered paper session on Thoracic cancers
Resources:
Slides
Webcast
Invited Discussant abstracts 376O and 377O
Presenter: Anne-Marie Dingemans
Session: Proffered paper session on Thoracic cancers
Resources:
Slides
Webcast